Welcome to CDC stacks |

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA

Published Date:

Mar 2015

Publisher's site:

http://dx.doi.org/10.3201/eid2103.141313 New Site Icon

Source:

Emerg Infect Dis. 21(3):500-503.

[PDF-1.22 MB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Trieu, Lisa ; Proops, Douglas C. ; Ahuja, Shama D. ;

Description:

Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	14-1313.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

RIFAMPIN-RESISTANT TUBERCULOSIS IN THE UNITED STATES, 1998–2014

Personal Author:

Sharling, Lisa; Marks, Suzanne M.; Goodman, Michael; Chorba, Terence; Mase, Sundari;

Published Date:

Apr 10 2020

Source:

Clin Infect Dis. 70(8):1596-1605

Description:

BackgroundMonoresistance to rifamycins necessitates longer and more toxic regimens for tuberculosis (TB). We examined characteristics and mortality associated with rifampin-monoresistant (RMR) TB in the United States.MethodsWe analyzed Mycobacterium ...

Public Access
Available on:

April 10, 2021
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

Personal Author:

Marks, Suzanne M.; Mase, Sundari R.; Morris, Sapna Bamrah;

Published Date:

Jun 15 2017

Source:

Clin Infect Dis. 64(12):1670-1677

Description:

BackgroundEvidence-based recommendations for treating persons having presumed latent tuberculosis (LTBI) after contact to infectious multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small observational studies...

File Type:

[PDF - 193.88 KB]
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

Personal Author:

Osman, Muhammad; Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Moore, Brittany K.; Hicks, Robert M.; Achar, Jay; Amanullah, Farhana; Barry, Pennan; Becerra, Mercedes; Chiotan, Domnica I.; Drobac, Peter C.; Flood, Jennifer; Furin, Jennifer; Gegia, Medea; Isaakidis, Petros; Mariandyshev, Andrei; Ozere, Iveta; Shah, N. Sarita; Skrahina, Alena; Yablokova, Elena; Seddon, James A.; Hesseling, Anneke C.;

Corporate Authors:

for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB

Published Date:

Mar 2019

Source:

Emerg Infect Dis. 25(3):441-450

Description:

Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriol...

File Type:

[PDF - 961.79 KB]
Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru

Personal Author:

Nathavitharana, Ruvandhi R.; Shi, Cynthia X.; Chindelevitch, Leonid; Calderon, Roger; Zhang, Zibiao; Galea, Jerome T.; Contreras, Carmen; Yataco, Rosa; Lecca, Leonid; Becerra, Mercedes C.; Murray, Megan B.; Cohen, Ted;

Published Date:

Nov 2017

Source:

Emerg Infect Dis. 23(11):1887-1890.

Description:

Because within-host Mycobacterium tuberculosis diversity complicates diagnosis and treatment of tuberculosis (TB), we measured diversity prevalence and associated factors among 3,098 pulmonary TB patients in Lima, Peru. The 161 patients with polyclon...

File Type:

[PDF - 812.55 KB]
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-Resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands

Personal Author:

Mase, Sundari R.; Jereb, John A.; Gonzalez, Daniel; Martin, Fatma; Daley, Charles L.; Fred, Dorina; Loeffler, Ann; Menon, Lakshmy; Morris, Sapna Bamrah; Brostrom, Richard; Chorba, Terence; Peloquin, Charles A.;

Published Date:

Apr 2016

Source:

Pediatr Infect Dis J. 35(4):414-421.

Description:

BackgroundIn the Federated States of Micronesia (FSM) and then the Republic of the Marshall Islands (RMI), levofloxacin pharmacokinetics (PK) were studied in children receiving directly observed once-daily regimens (10 mg/kg, age >5 years; 15–20 mg...

File Type:

[PDF - 1.64 MB]